Last updated Nov 17, 2026. 88 unique records for (ARA-290 OR ARA290 OR "ARA 290" OR cibinetide). 2026 is a partial year. The query uses the laboratory names ARA-290 / ARA290 and the International Nonproprietary Name cibinetide. This page does not treat the named peptide as an approved drug or as a treatment. Source on PubMed
RC-ARA290 · Tissue Signaling Research
RC-ARA290
Tissue Signaling Research
Vial sizes for laboratory supply, not a protocol.
Key specifications
Catalog facts are taken from the live PEPTIDEA™ listing. Formula and molecular weight are from PubChem. Sequence is omitted here.
- Catalog title
- RC-ARA290 | Tissue Signaling Research
- Research focus
- Tissue Signaling Research
- Also described as
- ARA-290 · cibinetide · EPO-derived helix-B peptide
- Format
- Lyophilized research peptide
- Catalog status
- In stock (public listing)
- Presentations
- 10 mg vial (catalog presentation)Catalog sizes, not a protocol
- Molecular formula
- C51H84N16O21PubChem CID 91810664 (cibinetide)
- Molecular weight
- 1257.3PubChem average for CID 91810664
- Receptor context
- Described as a non-erythropoietic EPO-derived peptide that binds the innate repair receptor (EPOR / β-common receptor, CD131) in laboratory literatureLiterature description; research context only
- Sequence
- Not reproduced hereSee primary literature / PubChem
- Researcher access
- Sign-in required to view pricing
- PubMed records
- 88 uniqueQuery above, Nov 17, 2026
Catalog notes & use limitations
Research-catalog framing only. This section does not describe effects in people or study outcomes.
Catalog notes
Listed under Tissue Signaling Research
RC-ARA290 appears in the PEPTIDEA™ Cellular Signaling Research collection with other tissue-signaling materials, including RC-BPC and RC-TB4.
Tool compound, not an approved drug
Published papers describe ARA-290 / cibinetide as an investigational, non-erythropoietic EPO-derived peptide. This page does not present it as a treatment or as an approved medicine.
10 mg catalog presentation
The public listing is a simple product. 10 mg is inferred from SKU RC-416-10. Catalog size is not a protocol.
Use limitations
Research use only
Not for human or veterinary use. Not a drug, not a cosmetic, and not medical advice. Not presented here as a treatment or weight-management product.
No outcome or dosing information
This page does not list administration amounts, schedules, or clinical results. Catalog vial sizes are presentations of the research material, not a protocol.
Confirm details from primary sources
Formula and molecular weight are cited from PubChem when a single compound applies; otherwise see the catalog notes. Sequence is omitted. Read the original papers for laboratory context — results stay in the original publications.
Specifications
Laboratory-catalog and public-chemistry details. Items without a cited source are marked.
| Catalog title | RC-ARA290 | Tissue Signaling Research |
|---|---|
| Category | Tissue Signaling Research (Cellular Signaling Research) |
| Associated names | ARA-290; cibinetide; non-erythropoietic EPO-derived peptide |
| Format | Lyophilized research peptide |
| Public catalog status | In stock (as of Nov 17, 2026) |
| Catalog presentations | 10 mg vial (catalog presentation) — sizes of the research material, not a use protocol |
| Molecular formula | C51H84N16O21 (PubChem CID 91810664 (cibinetide), retrieved Nov 17, 2026) |
| Molecular weight | 1257.3 (PubChem average for CID 91810664) |
| InChIKey | WZTIQQBMSJTRBR-WYKNNRPVSA-N (PubChem) |
| Receptor context | Published papers describe ARA-290 / cibinetide as an 11-amino-acid peptide designed from the helix-B surface of erythropoietin, intended as a tool compound for the tissue-protective EPOR–CD131 heteromer without stimulating red-cell production. That is a mechanism-class description, not a use claim. It is not an approved drug. |
| Sequence | Not reproduced on this page. See primary literature and the PubChem record. |
| Pricing | Visible after researcher sign-in |
Research literature
These are Peptidea-written summaries of selected publications, prepared so you can stay on peptidea.net. Each card describes what was studied — the research question, study type, and mechanism or setting. We do not restate results, endpoints, or protocols. Full papers remain with their publishers; a small PubMed source link is included only for citation.
van Velzen et al.
This article describes ARA 290 as an investigational EPO-derived peptide and discusses its study in small-fiber neuropathy research settings. It is included as identity and literature-context material, not as a treatment recommendation for this catalog item.
Clinical-investigation findings, dosing, and any efficacy or safety conclusions in the article are not restated on this page.
van Rijt et al.
This paper studied ARA290, described as a non-erythropoietic erythropoietin derivative, in a mouse model of renal ischemia and reperfusion. It is a laboratory animal study, not a clinical trial of this vial.
Injury, function, and other experimental results in the paper are not reproduced here.
Nairz et al.
This paper examined cibinetide in experimental models of innate immune cell function. It is included as mechanism-class literature for the named peptide, not as a study of this catalog vial in people.
Immunological and disease-model findings in the paper are not restated on this page.
Wang et al.
This paper studied ARA290 and the β-common receptor in a mouse model of cerebral ischemia. It is a laboratory animal study of receptor-pathway context, not a use guide for this material.
Histology, behavioral, and other findings in the paper are not reproduced here.
Original titles are omitted or neutralized when they use clinical-outcome wording. Counts and the optional source links use the query (ARA-290 OR ARA290 OR "ARA 290" OR cibinetide). Source on PubMed
Storage & handling
General laboratory-catalog guidance for layout purposes. Always follow the vial label and your institution’s written procedures.
- Handle as a lyophilized research material intended for laboratory use only.
- Store according to the conditions printed on the label and in any compound document provided to approved researchers.
- Protect closed vials from moisture and unnecessary temperature swings.
- If reconstitution is performed, use only the laboratory’s own written procedures. This page does not provide volumes, solvents, or working concentrations.
- This material is not for human or veterinary use and is not medical advice.
Research Use Only. Not for human or veterinary use. Not medical advice. PEPTIDEA™ is a trademark of Grey Bug LLC.





